J. Grau

发表

Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments

M. Bernal-Sprekelsen, I. Vilaseca, J. Berenguer, 2021, Head & neck.

Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)

M. Hidalgo, R. Hitt, C. Jara, 2007 .

Cancer diagnosis disclosure in a Spanish hospital.

N. Viñolas, J. Grau, J. Estapé, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic adenoid cystic carcinoma of the salivary gland responding to cetuximab plus weekly paclitaxel after no response to weekly paclitaxel alone

J. Grau, M. Caballero, Aaron E Sosa, 2013, Head & neck.

Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

R. Grimalt, J. Albanell, C. Montagut, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.

J. Tisaire, J. Sastre, A. Rueda, 2005, European journal of cancer.

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

C. García-Girón, R. Hitt, A. Ocaña, 2020, Clinical and Translational Oncology.

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

C. García-Girón, R. Hitt, C. Jara-Sánchez, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Response to metronomic chemotherapy in a metastatic adenoid cystic carcinoma of the parotid gland

L. Visa, J. Grau, M. Caballero, 2010 .

Breast cancer in Rubens paintings

J. Grau, Jorge Estapé, Matías Diat-Padrón, 2001, Breast Cancer Research and Treatment.

Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer

D. Fuster, J. Setoain, R. Herranz, 1997, European Journal of Nuclear Medicine.

Ultrastructural and Molecular Heterogeneity in Non-Small Cell Lung Carcinomas: Study of 110 Cases and Review of the Literature

Antonio Martínez, P. Fernández, A. Nadal, 2002, Ultrastructural pathology.

Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur

B. Mellado, J. Albanell, P. Gascón, 2004, Oncology.

Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot study

J. Carles, P. Gascón, M. Monzó, 2007, Acta oto-laryngologica.

Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making

I. Vilaseca, J. Berenguer, A. Muxi, 2022, European Archives of Oto-Rhino-Laryngology.

Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC)

J. Carles, R. Hitt, H. Cortés-Funes, 2005 .

Outcome of patients after curative resection of pulmonary metastases.

J. Gimferrer, E. Canalís, J. Estapé, 1998, International surgery.

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.

B. Cirauqui, R. Hitt, S. Vázquez Estévez, 2022, Oral oncology.

Dihydropyrimidine dehydrogenases and cytidine‐deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy

A. Navarro, M. Monzó, C. Conill, 2008, Journal of surgical oncology.

Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC).

R. Hitt, H. Cortés-Funes, A. Irigoyen, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

C. Cordon-Cardo, J. Domingo-Doménech, R. Mesía, 2016, Oncology.

Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC).

C. García-Girón, R. Hitt, H. Cortés-Funes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy of the brain in elderly patients

J. Grau, E. Verger, J. Grau, 2000 .

Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision‐tree analysis

M. Bernal-Sprekelsen, I. Vilaseca, A. Nadal, 2018, Head & neck.

Transoral laser microsurgery for locally advanced (T3–T4a) supraglottic squamous cell carcinoma: Sixteen years of experience

M. Bernal-Sprekelsen, I. Vilaseca, J. Berenguer, 2016, Head & neck.

Survival after chemotherapy with cisplatin and infusion of bleomycin prior to local-regional treatment in pyriform sinus cancer.

J. Traserra, J. Estapé, J. Fírvida, 1996, Tumori.

Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1–T4 pharyngo-laryngeal cancers

M. Bernal-Sprekelsen, J. Guilemany, I. Vilaseca, 2007, European Archives of Oto-Rhino-Laryngology.

Follow-up study in head and neck cancer: cure rate according to tumor location and stage.

C Arias, J Traserra, J J Grau, 1997, Oncology.

SEOM clinical guideline in nasopharynx cancer (2017)

R. Mesía, B. Castelo, E. del Barco, 2017, Clinical and Translational Oncology.

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

R. Hitt, J. García-Saenz, H. Cortés-Funes, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

Ulrich Keilholz, Thomas Gauler, J. Machiels, 2015, The Lancet. Oncology.

Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer.

L. Grande, J. Visa, J. Fuster, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up.

N. Viñolas, C. Pera, J. Estapé, 1991, Annals of surgery.

Spanish consensus for the management of sinonasal tumors.

I. Alobid, F. López, J. Medina, 2017, Acta otorrinolaringologica espanola.

Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel

M. Monzó, L. Alós, J. Grau, 2009, The Laryngoscope.

Emerging systemic antitarget treatment for differentiated thyroid carcinoma

M. Mora, N. Basté, J. Grau, 2021, Current opinion in oncology.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers.

James A McCaul, Gregor Sersa, Ales Groselj, 2016, European journal of cancer.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer.

Gregor Sersa, Ales Groselj, Remco de Bree, 2016, European journal of cancer.

[New antitarget antineoplastic drugs. Clinical indications in the treatment of cancer].

J. Grau, M. Caballero, Andrea Tagliapetra, 2011, Medicina clinica.

Chronic oral etoposide in non-small cell lung carcinoma.

C. Agustí, N. Viñolas, J. Ramírez, 1992, European journal of cancer.

Intracavitary oxytetracycline in malignant pericardial tamponade.

N. Viñolas, J. Estapé, J. Grau, 1992, Oncology.

Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients

M. Monzó, J. Blanch, E. Verger, 2009, Acta oto-laryngologica.

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy

M. Monzó, C. Fondevila, J. Fuster, 2006, World journal of surgical oncology.

Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients.

C. Pera, C. Pera, J. Terès, 1993, European journal of cancer.

Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV.

A. Vilalta, A. Biete, J. Blanch, 1996, European journal of cancer. Part B, Oral oncology.

Multidisciplinary Approach in Advanced Cancer of the Oral Cavity: Outcome with Neoadjuvant Chemotherapy according to Intention-to-Treat Local Therapy

J. Blanch, J. Estapé, E. Verger, 2002, Oncology.

Age: a critical factor in cancer management. A prospective comparative study of 400 patients.

Grau, N. Viñolas, M. Muñoz, 1999, Age and ageing.

Chronic oral etoposide in advanced breast cancer

B. Mellado, N. Viñolas, J. Estapé, 2004, Cancer Chemotherapy and Pharmacology.

Short communication Chronic oral etoposide in advanced breast cancer

B. Mellado, J. Grau, H. Palombo, 1994 .

Thyroid cancer: SEOM clinical guidelines

J. Capdevila, E. Grande, J. Trigo, 2014, Clinical and Translational Oncology.

[Autochthonous vaginal myiasis].

R. Alonso, A. Calderón, J. Grau, 1994, Enfermedades infecciosas y microbiologia clinica.

The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer

O. Reig, J. Blanch, J. Grau, 2017, Oncology.

Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.

B. Cirauqui, J. García-Saenz, R. Mesía, 2017, International journal of radiation oncology, biology, physics.

SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013

R. Mesía, M. Pastor, J. Grau, 2013, Clinical and Translational Oncology.

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

J. Machiels, T. Gauler, N. Gibson, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

The role of chemotherapy in advanced oral cavity cancer

M. Bernal-Sprekelsen, J. Blanch, J. Grau, 2009 .

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013

R. Mesía, M. Pastor, J. Grau, 2013, Clinical and Translational Oncology.

Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy

J. Grau, A. Sosa, M. Caballero, 2014, European Archives of Oto-Rhino-Laryngology.

Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study

O. Reig, M. García-Morillo, J. Grau, 2018, The Annals of otology, rhinology, and laryngology.

Neck mass and tracheostomy in a young lady depicted by Piero di Cosimo

A. Trilla, J. Grau, M. Caballero, 2019, Hormones.

Influence of allelic variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab

E. Verger, J. Grau, C. Muñoz, 2016, European Archives of Oto-Rhino-Laryngology.

[Flagellated pigmentation caused by bleomycin. Presentation of 2 cases].

A. Azon, J. Grau, J. Mascaró, 1990, Medicina cutanea ibero-latino-americana.

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.

J. Carles, J. García-Saenz, R. Mesía, 2016, International journal of radiation oncology, biology, physics.

Prognosis in Women with Breast Cancer and Private Extra Insurance Coverage

C. Caso, Albert Biete, Juan J. Grau, 2013, Annals of Surgical Oncology.

Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.

M. Bernal-Sprekelsen, J. Domingo-Doménech, J. Augé, 2007, Archives of otolaryngology--head & neck surgery.

Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer

C. Conill, J. Domingo-Doménech, F. Lomeña, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Impact of adjuvant chemotherapy in the long‐term outcome of patients with resected gastric cancer

J. Fuster, M. Martín, J. Bordas, 2003, Journal of surgical oncology.

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

J. Machiels, T. Gauler, F. Caponigro, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Sorafenib in metastatic thyroid cancer.

J. Tabernero, J. Capdevila, E. Grande, 2012, Endocrine-related cancer.

Cancer knowledge among Spanish women participating in literacy schemes

J. Estapé, J. Grau, T. Estapé, 2003, Psycho-oncology.

Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report.

J. Capdevila, J. Grau, K. Holub, 2018, Oncology letters.

Medicine in the Prado Museum, Madrid, Spain: Signs of illness, and medical procedures in the art works.

Á. Iranzo, J. Grau, Cristina Garrido, 2022, Medicina clinica.

A single-arm phase II trial to evaluate the combination of cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (TPF) as induction chemotherapy (IC) in patients (pts) with unresectable SCCHN.

J. García-Saenz, R. Mesía, A. Irigoyen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).

I. Matos, J. Capdevila, E. Grande, 2017, European journal of endocrinology.

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

R. Hitt, J. García-Saenz, A. Irigoyen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.

J. Carles, J. García-Saenz, R. Mesía, 2016, International journal of radiation oncology, biology, physics.